Skip to main content
. 2021 Jan 23;2021:6688138. doi: 10.1155/2021/6688138

Figure 3.

Figure 3

Comparative survival outcomes according to grouping composite disease stage and pretreatment SIRI groups (red line: Group 1, IIIB and SIRI < 1.9; dark blue line: Group 2, IIIB and SIRI ≥ 1.9; green line: Group 3, IIIC and SIRI < 1.9; and orange line: Group 4, IIIC and SIRI ≥ 1.9): (a) progression-free survival; (b) overall survival.